ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement

Menlo Park, CA
Wednesday, December 17, 2014

Archer Daniels Midland Company to apply DNA2.0’s proprietary protein engineering technology, ProteinGPS®, to ADM’s industrial enzyme engineering process.

Gene synthesis and bioengineering company DNA2.0 Inc. announces today that it has entered into a technology access and services agreement with Archer Daniels Midland Company (ADM) to apply DNA2.0’s proprietary protein engineering technology, known as “ProteinGPS®” to ADM’s industrial enzyme engineering process.

“We are extremely excited that the global leader ADM has adopted our ProteinGPS engineering platform. This proprietary bioengineering technology has now been validated through many scientific collaborations, peer-reviewed scientific publications and strong underlying IP. It is exciting to see broad adoption of the technology with partners ranging from Fortune 500 companies to small startups, and in commercial fields ranging from chemical biocatalysis to therapeutic proteins,” said Claes Gustafsson, DNA2.0’s Chief Commercial Officer. “Our ProteinGPS technology allows us to engineer any measurable biological function, such as activity, stability, immunogenicity, substrate specificity, manufacturability, etc., using only a few hundred samples in real commercial endpoint application assays.”

“ADM is eager to work with DNA2.0 to enhance and expand our R&D technology portfolio in the area of protein engineering. We truly appreciate DNA2.0’s GPS technology platform and DNA2.0’s expertise in bioengineering, and we look forward to a productive collaboration in producing the most efficient enzymes in the shortest possible timeframe,” said Dirk Reif, sweetener development scientist at ADM.

About DNA2.0: 
DNA2.0 is the leading bioengineering solutions provider, offering an integrated pipeline of solutions including gene design, optimization and synthesis, and platforms for protein and strain engineering. DNA2.0 explores novel applications for synthetic genes and the synergy between efficient gene design and protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. Visit

About ADM: 
For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM) have transformed crops into products that serve the vital needs of a growing world. Today, we’re one of the world’s largest agricultural processors and food ingredient providers, with more than 33,000 employees serving customers in more than 140 countries. With a global value chain that includes more than 470 crop procurement locations, 285 ingredient manufacturing facilities, 40 innovation centers and the world’s premier crop transportation network, we connect the harvest to the home, making products for food, animal feed, chemical and energy uses. Learn more at